Treatment with I3C can also suppress the progression of inflammation-related lung cancer in mice by reducing the expression of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) (Song et al., 2015). Here, IL6 is linked to lung carcinoma.